Assessing AI: Algorithmic Accountability, Data Bias and the Regulatory Landscape
While the industry is still in the early phases of determining how to best tap AI’s potential, there are significant opportunities ahead. Learn more in OTR.
While the industry is still in the early phases of determining how to best tap AI’s potential, there are significant opportunities ahead. Learn more in OTR.
There are two methods of underwriting. One is not intellectually satisfying, the other is challenging. Learn more.
Consider some surprising facts about winter sport risks, including participation, fatality and mindset trends for underwriters to watch. Read more.
Children have not been spared from COVID-19. Review research into multi-system inflammatory syndrome in children (MIS-C), including timing, symptomatology, and complication potential. Read more.
Foreign national business has been growing in the US for several years. High-net-worth individuals want to diversify their portfolios into US investments which include life insurance, yet understanding the foreign national segment can be challenging. […]
Tetrahydrocannabinol (THC) use has increased substantially in the last decade. Curious what the science says about health impacts and mortality implications, and how use and age patterns can guide underwriting decisions? Read more.
There is no guide for a pandemic, but insurers can learn lessons in compassion, communication, and common purpose. Gain views from three leaders in OTR.
Well rounded, highly educated, younger and growing in numbers. The profession of Life Underwriter is changing. Curious? Read more in OTR.
In the ideal world, a life underwriter would have all the information necessary to assess risk. But in reality, such data can be elusive. Get pragmatic best practices in OTR.
As diabetes reaches record levels, could the standard glycated hemoglobin A1c test to detect diabetes also serve as a blood biomarker for mortality? Rethink the purpose of this popular test.
Copyright © On The Risk 2020